AGT's Jeff Galvin speaks on panel at the BIO CEO & Investor Conference on Feb 10-11. The panel discussed IPO trends and outlook for 2020. The 2020 BIO CEO & Investor Conference is one of the largest independent investor conferences focused on established and emerging publicly traded and select private biotech companies. Experience the best of biotech with two days of productive partnering meetings with institutional and early-stage investors, industry analysts, and senior biotechnology executives, in one location. About the conference.
Subscribe to our YouTube Channel